Mar 18, 2019 / 10:00PM GMT
Operator
Greetings, and welcome to the Innovate Biopharmaceuticals Corporate and Operational Progress Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Jennifer Zimmons, Investor Relations for Innovate Biopharmaceuticals. Please go ahead, Jennifer.
Jennifer K. Zimmons - Strategic Growth International, Inc. - MD
Thank you, Kevin. Good morning, and thank you for joining us to discuss our recent business progress and Innovate's Full Year 2018 Financial Results and Corporate Highlights Conference Call. The press release containing the company's financial results for 2018 was issued earlier.
Joining our call are Steve Laumas, Chief Executive Officer; Patrick -- and Patrick Griffin, Chief Medical Officer. Jay Madan, Chief Business Officer, will also be joining for the Q&A session.
Before we begin, I'd like to remind everyone that this conference call includes forward-looking statements. Each forward-looking statement contained in this call is subject
Q4 2018 Innovate Biopharmaceuticals Inc Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers